UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

Epilepsia (Copenhagen), 2013-03, Vol.54 (3), p.551-563

2013

Volltextzugriff (PDF)

Pregabalin Pharmacology and Its Relevance to Clinical Practice

Epilepsia (Copenhagen), 2004-01, Vol.45 (s6), p.13-18

Ben‐Menachem, Elinor

2004

Volltextzugriff (PDF)

Cannabinoids for epilepsy: What do we know and where do we go?

Epilepsia (Copenhagen), 2018-02, Vol.59 (2), p.291-296

2018

Volltextzugriff (PDF)

Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open‐label extension of phase III randomized trials: Study 307

Epilepsia (Copenhagen), 2018-04, Vol.59 (4), p.866-876

2018

Volltextzugriff (PDF)

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies

Epilepsia (Copenhagen), 2013-08, Vol.54 (8), p.1481-1489

2013

Volltextzugriff (PDF)

Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study

Epilepsia (Copenhagen), 2018-02, Vol.59 (2), p.479-491

2018

Volltextzugriff (PDF)

Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data

Epilepsia (Copenhagen), 2018-09, Vol.59 (9), p.1727-1739

2018

Volltextzugriff (PDF)

Serum Markers of Neuronal Damage and Astrocyte Activity in Patients with Chronic Epilepsy: Elevated Levels of Glial Fibrillary Acidic Protein

Acta neurologica Scandinavica, 2023, Vol.2023, p.1-5

2023

Volltextzugriff (PDF)

ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes

Epilepsia (Copenhagen), 2006-07, Vol.47 (7), p.1094-1120

2006

Volltextzugriff (PDF)

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy

Epilepsia (Copenhagen), 2019-12, Vol.60 (12), p.2437-2447

2019

Volltextzugriff (PDF)

Estimating Long‐Term Vagus Nerve Stimulation Effectiveness: Accounting for Antiepileptic Drug Treatment Changes

Neuromodulation (Malden, Mass.), 2018-12, Vol.21 (8), p.797-804

2018

Volltextzugriff (PDF)

Long‐term safety of perampanel and seizure outcomes in refractory partial‐onset seizures and secondarily generalized seizures: Results from phase III extension study 307

Epilepsia (Copenhagen), 2014-07, Vol.55 (7), p.1058-1068

2014

Volltextzugriff (PDF)

Onset of efficacy and adverse events during Cenobamate titration period

Acta neurologica Scandinavica, 2022-09, Vol.146 (3), p.265-275

2022

Volltextzugriff (PDF)

Vigabatrin: 2008 Update

Epilepsia (Copenhagen), 2009-02, Vol.50 (2), p.163-173

2009

Volltextzugriff (PDF)

Medical management of refractory epilepsy—Practical treatment with novel antiepileptic drugs

Epilepsia (Copenhagen), 2014-01, Vol.55 (s1), p.3-8

Ben‐Menachem, Elinor

2014

Volltextzugriff (PDF)

Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate

Acta neurologica Scandinavica, 2020-05, Vol.141 (5), p.397-404

2020

Volltextzugriff (PDF)

Perampanel for adjunctive treatment of partial‐onset seizures: A pooled dose–response analysis of phase III studies

Epilepsia (Copenhagen), 2014-03, Vol.55 (3), p.423-431

2014

Volltextzugriff (PDF)

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations

Epilepsia open, 2023-12, Vol.8 (4), p.1241-1255

2023

Volltextzugriff (PDF)

Pharmacokinetics of Levetiracetam during Pregnancy, Delivery, in the Neonatal Period, and Lactation

Epilepsia (Copenhagen), 2007-06, Vol.48 (6), p.1111-1116

2007

Volltextzugriff (PDF)

Issues related to development of new antiseizure treatments

Epilepsia (Copenhagen), 2013-08, Vol.54 (s4), p.24-34

2013

Volltextzugriff (PDF)

Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies

Journal of neuroimmunology, 2017-05, Vol.306, p.25-30

2017

Volltextzugriff (PDF)

Complications and safety of vagus nerve stimulation: 25 years of experience at a single center

Journal of neurosurgery. Pediatrics, 2016-07, Vol.18 (1), p.97-104

2016

Volltextzugriff (PDF)

Weight issues for people with epilepsy—A review

Epilepsia (Copenhagen), 2007-12, Vol.48 (s9), p.42-45

Ben‐Menachem, Elinor

2007

Volltextzugriff (PDF)

Vagus-nerve stimulation for the treatment of epilepsy

Lancet neurology, 2002-12, Vol.1 (8), p.477-482

Ben-Menachem, Elinor

2002

Volltextzugriff (PDF)

Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial

Epilepsia open, 2021-09, Vol.6 (3), p.618-623

2021

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(181)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

Pregabalin Pharmacology and Its Relevance to Clinical Practice

Cannabinoids for epilepsy: What do we know and where do we go?

Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open‐label extension of phase III randomized trials: Study 307

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies

Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study

Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data

Serum Markers of Neuronal Damage and Astrocyte Activity in Patients with Chronic Epilepsy: Elevated Levels of Glial Fibrillary Acidic Protein

ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy

Estimating Long‐Term Vagus Nerve Stimulation Effectiveness: Accounting for Antiepileptic Drug Treatment Changes

Long‐term safety of perampanel and seizure outcomes in refractory partial‐onset seizures and secondarily generalized seizures: Results from phase III extension study 307

Onset of efficacy and adverse events during Cenobamate titration period

Vigabatrin: 2008 Update

Medical management of refractory epilepsy—Practical treatment with novel antiepileptic drugs

Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate

Perampanel for adjunctive treatment of partial‐onset seizures: A pooled dose–response analysis of phase III studies

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations

Pharmacokinetics of Levetiracetam during Pregnancy, Delivery, in the Neonatal Period, and Lactation

Issues related to development of new antiseizure treatments

Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies

Complications and safety of vagus nerve stimulation: 25 years of experience at a single center

Weight issues for people with epilepsy—A review

Vagus-nerve stimulation for the treatment of epilepsy

Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial

Suchergebnisse filtern